Rapid cardiovascular disease test VMPO18

creatine kinaseserumplasma

This kit is specifically designed for in vitro quantitative screening of the concentration of Creatine kinase-MB (CK-MB) protein in human serum, plasma, and whole blood samples. Automated and objective results in 15 minutes by immunofluorescent assay. Advantages – Helps to evaluate and examine the diagnosis, prognosis, and evaluation of heart damage – Easy-to-understand interpretation by printer – Can reconnect to the old results by ID Chip – Easy-operable interface – Maximized accuracy and sensitivity – Minimum time interval to maximum accuracy Box Content – ID Chip – Sample Diluent – Pipette – User Manual